Overview
On February 27, 2026, Amberjack Capital Partners and related entities sold a total of 6,620,497 shares of Innovex International, Inc. (NASDAQ: INVX) common stock at a per-share price of $24.5913, resulting in aggregate proceeds of approximately $162.6 million. Since that trade date the stock has traded up to $26.35, a price that represents a 53% gain over the past six months and a 44% return over the past year.
Breakdown of the sales
The transactions were executed across several affiliated vehicles as follows:
- Amberjack Capital Fund II, L.P. - 4,902,244 shares sold
- Innovex Co-Invest Fund II, L.P. - 1,144,635 shares sold
- Innovex Co-Invest Fund, L.P. - 271,279 shares sold
- Intervale Capital Fund II, L.P. - 234,009 shares sold
- Intervale Capital Fund III, L.P. - 60,217 shares sold
- Intervale Capital Fund II-A, L.P. - 116 shares sold
Holdings after the transactions
Following the dispositions, the reported holdings for the named funds are:
- Amberjack Capital Fund II, L.P. holds 16,871,374 shares
- Innovex Co-Invest Fund II, L.P. holds 3,939,330 shares
- Innovex Co-Invest Fund, L.P. holds 933,624 shares
- Intervale Capital Fund II, L.P. holds 805,355 shares
- Intervale Capital Fund III, L.P. holds 207,240 shares
- Intervale Capital Fund II-A, L.P. holds 399 shares
Jason Turowsky, Managing Partner of Amberjack Management, LLC, is identified in association with these transactions.
Company results and financials
Innovex disclosed fourth-quarter results that were mixed versus consensus estimates. Adjusted earnings per share for the quarter were $0.20, below the analyst consensus of $0.29. Revenue for the period totaled $273.6 million, which exceeded the $239.47 million estimate and represented a 9% year-over-year increase as well as a 14% sequential rise from the prior quarter.
Selling stockholder offering
Certain affiliates of Amberjack Capital Partners, L.P. filed paperwork to offer 5,750,000 shares of Innovex common stock in a public offering. The selling stockholders intend to grant underwriters a 30-day option to purchase up to 862,500 additional shares. The filing specifies that Innovex itself will not sell any shares in this offering and will not receive proceeds from the sale.
Market context and closing notes
The transactions and the selling stockholder offering are distinct actions recorded in public filings and company results published for the fourth quarter. The information above reflects the quantities, prices, holdings and offer terms disclosed in those filings and the company-reported quarterly metrics.
Data and transaction details are reported as disclosed in company and filing statements.